Skip to main content
BIR Issuancesby BetterGov.phBeta
Official source
Browse issuances
Revenue Memorandum Circular · RMC

RMC No. 51-2022

To publish the Food and Drug Administration letter endorsing updates to the List of VAT-Exempt Medicines under Republic Act No. 11534 (CREATE Act).

Bureau of Internal RevenueIndependent research copy
Document type
RMC
Number
51
Year
2022
Text quality
Not specified

Document text

Reference copy · verify against the official source
RMC No. 51-2022, issued April 21, 2022, publishes a Food and Drug Administration letter endorsing updates to the List of VAT-Exempt Medicines under Republic Act No. 11534 (CREATE Act). The updates cover certain medicines for COVID-19 treatment and hypertension and correct one medicine for cancer. The provided excerpt does not name the specific medicines or reproduce the itemized list, so those details must be confirmed from the full circular.